Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.
Does that make it too soon to be predicting likely candidates for best picture? Not if you’re an ardent cinephile or industry ...